Moreover, the sarcopenia group showed significantly increased levels of various hepatic function indicators, such as TBIL (P = 0.048), direct bilirubin (DBIL, P = 0.002), ALT (P = 0.017), AST (P = 0.017), alkaline phosphatase (ALP, P = 0.020), and gamma glutamyl transpeptidase (γ-GT, P = 0.032) compared with the non-sarcopenia group in patients with PLA. The gene discussed is GGTLC1; the disease is sarcopenia.